Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
Authors
Keywords
Venous thromboembolism, Metaanalysis, Hemorrhage, Anticoagulant therapy, Drug therapy, Cancer treatment, Network analysis, Anticoagulants
Journal
PLoS One
Volume 14, Issue 4, Pages e0214134
Publisher
Public Library of Science (PLoS)
Online
2019-04-02
DOI
10.1371/journal.pone.0214134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review
- (2018) Laurent Bertoletti et al. BLOOD REVIEWS
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial
- (2018) Cécile Tromeur et al. EUROPEAN RESPIRATORY JOURNAL
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results
- (2018) Philip S. Wells et al. JOURNAL OF MEDICAL ECONOMICS
- Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis
- (2017) Jonathan AC Sterne et al. HEALTH TECHNOLOGY ASSESSMENT
- Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials
- (2017) S. Laporte et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis
- (2017) Adem İ Diken et al. PHLEBOLOGY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada
- (2016) Peter Quon et al. JOURNAL OF MEDICAL ECONOMICS
- Ranking treatments in frequentist network meta-analysis works without resampling methods
- (2015) Gerta Rücker et al. BMC Medical Research Methodology
- Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The SURVET Study: A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial
- (2015) Giuseppe M. Andreozzi et al. CIRCULATION
- Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism
- (2015) Francis Couturaud et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism
- (2015) Antonio Gómez-Outes et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
- (2015) S. Kaatz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK
- (2015) Anamaria Vera Jugrin et al. THROMBOSIS AND HAEMOSTASIS
- Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis
- (2015) Diana M. Sobieraj et al. THROMBOSIS RESEARCH
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting
- (2015) Anamaria Vera Jugrin et al. JOURNAL OF MEDICAL ECONOMICS
- Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis
- (2015) A. T. Cohen et al. PLoS One
- The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
- (2014) C. Chai-Adisaksopha et al. BLOOD
- Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
- (2014) C. Kearon et al. BLOOD
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
- (2014) N. van Es et al. BLOOD
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
- (2014) EUROPEAN HEART JOURNAL
- Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism
- (2014) Lana A. Castellucci et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The global burden of unsafe medical care: analytic modelling of observational studies
- (2013) Ashish K Jha et al. BMJ Quality & Safety
- Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
- (2013) L. A. Castellucci et al. BMJ-British Medical Journal
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- Pulmonary embolism and deep vein thrombosis
- (2012) Samuel Z Goldhaber et al. LANCET
- Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
- (2012) Timothy A. Brighton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin for Preventing the Recurrence of Venous Thromboembolism
- (2012) Cecilia Becattini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
- (2012) B. D. Fox et al. BMJ-British Medical Journal
- Network meta-analysis, electrical networks and graph theory
- (2012) Gerta Rücker Research Synthesis Methods
- Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
- (2011) Jeroen P. Jansen et al. VALUE IN HEALTH
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII
- (2008) L. Eischer et al. ANNALS OF HEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started